
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis and Biological Evaluation of Pyrazoline and Pyrrolidine‐2,5‐dione Hybrids as Potential Antitumor Agents
Kalpana Tilekar, Neha Upadhyay, Franz‐Josef Meyer‐Almes, et al.
ChemMedChem (2020) Vol. 15, Iss. 19, pp. 1813-1825
Closed Access | Times Cited: 28
Kalpana Tilekar, Neha Upadhyay, Franz‐Josef Meyer‐Almes, et al.
ChemMedChem (2020) Vol. 15, Iss. 19, pp. 1813-1825
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds
Giovanna Li Petri, Maria Valeria Raimondi, Virginia Spanò, et al.
Topics in Current Chemistry (2021) Vol. 379, Iss. 5
Open Access | Times Cited: 171
Giovanna Li Petri, Maria Valeria Raimondi, Virginia Spanò, et al.
Topics in Current Chemistry (2021) Vol. 379, Iss. 5
Open Access | Times Cited: 171
Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 28
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 28
Recent advancement in pyrrolidine moiety for the management of cancer: A review
Rakesh Sahu, Kamal Shah, Rishabha Malviya, et al.
Results in Chemistry (2024) Vol. 7, pp. 101301-101301
Open Access | Times Cited: 14
Rakesh Sahu, Kamal Shah, Rishabha Malviya, et al.
Results in Chemistry (2024) Vol. 7, pp. 101301-101301
Open Access | Times Cited: 14
Synthesis, Biological Properties, In Silico ADME, Molecular Docking Studies, and FMO Analysis of Chalcone Derivatives as Promising Antioxidant and Antimicrobial Agents
Md. R. U. Ahsan, Sony Paul, Mohammad Sayed Alam, et al.
ACS Omega (2025)
Open Access | Times Cited: 1
Md. R. U. Ahsan, Sony Paul, Mohammad Sayed Alam, et al.
ACS Omega (2025)
Open Access | Times Cited: 1
Research progress in biological activities of succinimide derivatives
Zefeng Zhao, Jiangxin Yue, Xiaotong Ji, et al.
Bioorganic Chemistry (2020) Vol. 108, pp. 104557-104557
Closed Access | Times Cited: 65
Zefeng Zhao, Jiangxin Yue, Xiaotong Ji, et al.
Bioorganic Chemistry (2020) Vol. 108, pp. 104557-104557
Closed Access | Times Cited: 65
Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review)
Aeyaz Ahmad Bhat, Iqubal Singh, Nitin Tandon, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114954-114954
Closed Access | Times Cited: 35
Aeyaz Ahmad Bhat, Iqubal Singh, Nitin Tandon, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114954-114954
Closed Access | Times Cited: 35
Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery
Kalpana Tilekar, Onkar Shelke, Neha Upadhyay, et al.
Journal of Molecular Structure (2021) Vol. 1250, pp. 131767-131767
Closed Access | Times Cited: 35
Kalpana Tilekar, Onkar Shelke, Neha Upadhyay, et al.
Journal of Molecular Structure (2021) Vol. 1250, pp. 131767-131767
Closed Access | Times Cited: 35
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M. Ibrahim, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 11, pp. 1087-1107
Closed Access | Times Cited: 5
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M. Ibrahim, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 11, pp. 1087-1107
Closed Access | Times Cited: 5
Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy
Neha Upadhyay, Kalpana Tilekar, Fulvio Loiodice, et al.
Bioorganic Chemistry (2020) Vol. 107, pp. 104527-104527
Closed Access | Times Cited: 29
Neha Upadhyay, Kalpana Tilekar, Fulvio Loiodice, et al.
Bioorganic Chemistry (2020) Vol. 107, pp. 104527-104527
Closed Access | Times Cited: 29
Design, synthesis, anti-inflammatory evaluation, and molecular modelling of new coumarin-based analogs combined curcumin and other heterocycles as potential TNF-α production inhibitors via upregulating Nrf2/HO-1, downregulating AKT/mTOR signalling pathways and downregulating NF-κB in LPS induced macrophages
Lina M. A. Abdel Ghany, Botros Y. Beshay, Amal M. Youssef Moustafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 10
Lina M. A. Abdel Ghany, Botros Y. Beshay, Amal M. Youssef Moustafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 10
3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentials
Basma S. Gabr, Abdelrahman R. Shalabi, Mona F. Said, et al.
Future Medicinal Chemistry (2025), pp. 1-21
Closed Access
Basma S. Gabr, Abdelrahman R. Shalabi, Mona F. Said, et al.
Future Medicinal Chemistry (2025), pp. 1-21
Closed Access
Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agents
Shiv Kumar, Rupali Kohal, D.P. Mondal, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Shiv Kumar, Rupali Kohal, D.P. Mondal, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Synthesis of Hydroxysuccinimide Substituted Indolin-3-ones via One-Pot Cascade Reaction of o-Alkynylnitrobenzenes with Maleimides under Au(III)–Cu(II) Relay/Synergetic Catalysis
Guang Chen, Yue Wang, Jie Zhao, et al.
The Journal of Organic Chemistry (2021) Vol. 86, Iss. 21, pp. 14652-14662
Closed Access | Times Cited: 22
Guang Chen, Yue Wang, Jie Zhao, et al.
The Journal of Organic Chemistry (2021) Vol. 86, Iss. 21, pp. 14652-14662
Closed Access | Times Cited: 22
Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety
Lina Fernanda Castaño, Jairo Quiroga, Rodrigo Abonı́a, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12589-12589
Open Access | Times Cited: 15
Lina Fernanda Castaño, Jairo Quiroga, Rodrigo Abonı́a, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12589-12589
Open Access | Times Cited: 15
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 9, pp. 1540-1554
Open Access | Times Cited: 15
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 9, pp. 1540-1554
Open Access | Times Cited: 15
Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105350-105350
Closed Access | Times Cited: 15
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105350-105350
Closed Access | Times Cited: 15
Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells
Mariam M. Fakhry, Kazem Mahmoud, Mohamed S. Nafie, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1245-1245
Open Access | Times Cited: 11
Mariam M. Fakhry, Kazem Mahmoud, Mohamed S. Nafie, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1245-1245
Open Access | Times Cited: 11
Pyrrolidinedione-thiazolidinone hybrid molecules with potent cytotoxic effect in squamous cell carcinoma SCC-15 cells
Nataliya Finiuk, Edyta Kaleniuk, Serhii Holota, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 92, pp. 117442-117442
Open Access | Times Cited: 6
Nataliya Finiuk, Edyta Kaleniuk, Serhii Holota, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 92, pp. 117442-117442
Open Access | Times Cited: 6
Enclathration of Saturated Five-Membered Rings by Tricyclic Fused Host Systems
Brandon Barnardo, Benita Barton, Mino R. Caira, et al.
Crystal Growth & Design (2024)
Closed Access | Times Cited: 1
Brandon Barnardo, Benita Barton, Mino R. Caira, et al.
Crystal Growth & Design (2024)
Closed Access | Times Cited: 1
Synthetic approach of hydroxy-acetophenone-directed Rh(III) catalyzed C-H o-alkylation via 1,4 addition: Insights from DFT and docking methodology
Pakkirisamy Sivakumar, Pothapragada S. K. Prabhakar Ganesh, P. Muthuraja, et al.
Journal of Molecular Structure (2024) Vol. 1327, pp. 141248-141248
Closed Access | Times Cited: 1
Pakkirisamy Sivakumar, Pothapragada S. K. Prabhakar Ganesh, P. Muthuraja, et al.
Journal of Molecular Structure (2024) Vol. 1327, pp. 141248-141248
Closed Access | Times Cited: 1
Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K/AKT/mTOR pathway
Siqi Deng, Lu Wang, Shuang Tian, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 117, pp. 118007-118007
Closed Access | Times Cited: 1
Siqi Deng, Lu Wang, Shuang Tian, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 117, pp. 118007-118007
Closed Access | Times Cited: 1
Development and Investigation of Thiazolidinedione and Pyrazoline Compounds As Antiangiogenic Weapons Targeting VEGFR-2
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 22, pp. 1963-1986
Closed Access | Times Cited: 4
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 22, pp. 1963-1986
Closed Access | Times Cited: 4
Design, in silico studies, synthesis, and in vitro anticancer assessment of new naphthylidene isoxazolidinedione derivatives
Neha Upadhyay, Kalpana Tilekar, Aditi Oak, et al.
Vietnam Journal of Chemistry (2024) Vol. 62, Iss. 2, pp. 217-226
Open Access
Neha Upadhyay, Kalpana Tilekar, Aditi Oak, et al.
Vietnam Journal of Chemistry (2024) Vol. 62, Iss. 2, pp. 217-226
Open Access
Diaryl Pyrazoline, 1,3,4-Oxadizole, and 1,2,4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies
Abdullah Yahya Abdullah Alzahrani, Pratibha Gupta, Vijay Patil, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 2, pp. 375-391
Closed Access
Abdullah Yahya Abdullah Alzahrani, Pratibha Gupta, Vijay Patil, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 2, pp. 375-391
Closed Access
A novel pyrrolidine-2,5-dione derivative induced G2/M phase arrest and apoptosis of hepatocellular carcinoma HepG2 cells through inhibiting tubulin polymerization
Yingying Tian, Ailin Yang, Huiming Huang, et al.
Arabian Journal of Chemistry (2023) Vol. 17, Iss. 2, pp. 105550-105550
Open Access | Times Cited: 1
Yingying Tian, Ailin Yang, Huiming Huang, et al.
Arabian Journal of Chemistry (2023) Vol. 17, Iss. 2, pp. 105550-105550
Open Access | Times Cited: 1